Viewing Study NCT02482168


Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2026-01-06 @ 6:55 PM
Study NCT ID: NCT02482168
Status: COMPLETED
Last Update Posted: 2023-12-20
First Post: 2015-06-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the CD40 Agonistic Monoclonal Antibody APX005M
Sponsor: Apexigen America, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module